Immune checkpoint inhibitors (anti PD‐1 or anti PD‐L1) versus chemotherapy for second‐ or third‐line treatment of metastatic non‐small cell lung cancer

This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To evaluate the effectiveness and safety of immune checkpoint inhibitors (anti PD‐1 or anti PD‐L1) compared with standard chemotherapy for second‐ or third‐line treatment of metastatic non‐small cell lung cancer...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Cochrane Database Syst Rev
Hlavní autoři: Moraes, Fabio Y, Perry, Luke A, Penny‐Dimri, Jahan C, Ramson, Dhruvesh, de Castria, Tiago B, Bowman, Rayleen V, Santos, Fábio N, Fong, Kwun M, Riera, Rachel
Médium: Artigo
Jazyk:Inglês
Vydáno: John Wiley & Sons, Ltd 2017
Témata:
Medicine General & Introductory Medical Sciences
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6478330/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD012644
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky